The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
Trending Stocks This Week as Wall Street Sells off Amid Fed Remarks
Daily short sale tracking: Palantir's short volume increased by 16 million, with a short sale ratio of 15%
US Manufacturing Index Rises To 43, Highest Since 2020
As RFK Dust Settles, Drug Industry's Response Is Muted -- Barrons.com
Weekly Buzz: Not All Parties Last Forever
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Ultratech : yep imagining holding Pfizer and go out vote for trump and before he's even in white house portfolio dumps . I've been posting about how horrible he is for stocks and no one wants to admit it. he's their god